Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for Antepartum Bleeding
NCT03632824Completed
- Sponsor
- Hawler Medical University
- Start
- Feb 2016
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tranexamic acid in antepartum hemorrhage (APH) (2 arms), sponsored by Hawler Medical University. Primary endpoints: Cessation of vaginal bleeding as self-reported by women at 7 days, Gestational age at delivery and 2 more. Started Feb 2016; status: completed.
02
Drugs
tranexamic acid
03
Conditions
antepartum hemorrhage (APH)
Beyond the preview
Go deeper on NCT03632824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03632824.